Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21946779 | 0.98 | TSHR (0.48) | TSHRCYP3A4SOAT1MEN1KMT2A | |
| SCHEMBL11140956 | 0.98 | TSHR (0.48) | TSHRCYP3A4SOAT1MEN1KMT2A | |
| SCHEMBL8743883 | 0.93 | CES2 (0.50) | TSHRCYP3A4SOAT1MEN1KMT2A | |
| SCHEMBL11873756 | 0.93 | TSHR (0.52) | TSHRCYP3A4SOAT1MEN1KMT2A | |
| SCHEMBL3171180 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH | |
| SCHEMBL9312062 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH | |
| SCHEMBL28391149 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH | |
| SCHEMBL21815152 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH | |
| SCHEMBL28945727 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH | |
| SCHEMBL9312135 | 0.91 | CES2 (0.53) | CYP3A4SOAT1MEN1KMT2AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | TORAY INDUSTRIES, INC. (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20250368766-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-12-04 | — | — | US | disclosed |
| US-12473448-B2 | Recording method, and ink composition used in recording method | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-11-18 | — | — | US | disclosed |
| EP-4617333-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | DNP Fine Chemicals Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12338356-B2 | Nonaqueous ink composition, and recording method and recorded matter manufacturing method using same | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-06-24 | — | — | US | disclosed |
| EP-4549474-A1 | RESIN, RESIN DISPERSION, AND RESIN COMPOSITION | DNP Fine Chemicals Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| EP-4549524-A1 | AQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATTER, RECORDED MATTER, AND INKJET RECORDING DEVICE | DNP Fine Chemicals Co., Ltd. (JP) | 2025-05-07 | — | — | EP | disclosed |
| CN-115605352-B | Drying device, printing device and printing method | 株式会社理光 | 2025-03-04 | — | — | CN | disclosed |
| US-20250043140-A1 | NON-AQUEOUS INK COMPOSITION, INK SET, RECORDING METHOD USING SAME, METHOD FOR PRODUCING RECORDED MATTER, RECORDED MATTER, AND INKJET RECORDING APPARATUS | DNP FINE CHEMICALS CO., LTD. (JP) | 2025-02-06 | — | — | US | disclosed |
| US-20060089367-A1 | New indole or benzimidazole derivatives as CB1 inverse agonists | F. HOFFMANN-LA ROCHE AG (CH) | 2006-04-27 | — | — | US | disclosed |
| US-6967197-B2 | Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-11-22 | — | — | US | disclosed |
| US-6903218-B2 | Sulfonamide substituted chroman derivatives | BAYER PHARMACEUTICALS CORPORATION (US) | 2005-06-07 | — | — | US | disclosed |
| US-20030134849-A1 | Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-17 | — | — | US | disclosed |
| WO-2003018019-A2 | NEW USE OF CYCLIC COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-06 | — | — | WO | disclosed |
| EP-1259499-A1 | THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001060808-A1 | THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | WO | disclosed |
| US-6051586-A | HYPOGLYCEMIC AGENTS; ANTIDIABETIC AGENTS | BAYER CORPORATION (US) | 2000-04-18 | — | — | US | disclosed |
| EP-0499822-A1 | Bichromophore methine dyes | BASF Aktiengesellschaft (DE) | 1992-08-26 | — | — | EP | disclosed |
| US-4237067-A | REACTING SUBSTITUTED AMIDES WITH AN AMINE AND HEATING IN PRESCENCE OF A CATALYST | CHEMISCHE FABRIK STOCKHAUSEN & CIE. (DE) | 1980-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089367-A1 | New indole or benzimidazole derivatives as CB1 inverse agonists | CNR1, CNR2, GPR119 | TSHR 354/4885CYP3A4 567/4885SOAT1 1147/4885 |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | PPA1, PHOSPHO1, PHPT1 | TSHR 2576/4885CYP3A4 3020/4885SOAT1 2506/4885 |
| US-20030134849-A1 | Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors | MMP9, MMP1, MMP3 | TSHR 262/4885CYP3A4 3953/4885SOAT1 2477/4885 |
| US-20260125570-A1 | NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS | BMI1, IK, PRDM9 | TSHR 4439/4885CYP3A4 4504/4885SOAT1 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.